CodeSubmit / STUDIO deployment
CodeSubmit lifted EBITDA by turning healthcare RFP specs into reviewed buyer material.
The team used STUDIO to map ICD-10 and OPS procedure coding, LOINC and SNOMED patient history terminology, XSD validation routines, and FHIR export requirements before drafting RFP answers and customized pitch decks for owner review.
- ICD-10 / OPS
- procedure coding mapped to buyer requirements
- LOINC / SNOMED
- patient history terminology kept with source context
- XSD
- schemas and validation routines documented
- FHIR
- exports prepared for downstream publishing
RFP answers stopped treating ICD-10, OPS, LOINC, SNOMED, XSD, and FHIR as loose acronyms. The team reviewed source-backed drafts, edited the judgment calls, and sent buyer material with the technical proof attached.
CodeSubmit case note / owner-reviewed outputWhy STUDIO?
CodeSubmit sells into technical buyers with different clinical data requirements, validation rules, and procurement steps. Before the work, RFP responses and sales decks pulled from scattered documents, product memory, and one-off edits.
The team connected approved source material in STUDIO to the clinical coding spec, draft responses, and deck structure. The owner could inspect the source, change the answer, approve the version, and send material that matched the buyer's actual requirements.
Procedure coding
The response named how ICD-10 and OPS procedure codes moved from source material into the buyer's implementation review.
Patient history
LOINC and SNOMED references were attached to patient history requirements so reviewers could see the terminology, source, and exception path.
Validation
XSD schemas and validation routines were described as testable constraints, not loose implementation claims.
Publishing
FHIR exports were tied to downstream publishing, owner review, and the evidence trail behind each buyer-facing claim.
STUDIO flow
Clinical spec to reviewed buyer material.
ICD-10 / OPS / LOINC / SNOMED / XSD / FHIR
buyer material
drafted in STUDIO
reviewed output
Sources stay attached
Owner reviews clinical and schema claims
Response work ties back to EBITDA